Centre intégré universitaire de santé et de services sociaux de l’Ouest-de-l’Île-de-Montréal
Accueil Plan du site Courrier Portail Québec Passer directement au contenu

Aging and Alzheimer Disease Research

2001

Ramassamy C., Christen Y., Poirier J. (2001). Beta-amyloid peptide and apolipoprotein E in Alzheimer's disease . In Christen Y. (Ed.) , Advances in Ginko Biloba Extracts Research (pp. 72-89). Solal.

Ramassamy C., Krzywkowski P., Averill D., Lussier-Cacan S., Theroux L., Christen Y., Davignon J., Poirier J. (2001). Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain, Brain Res Mol Brain Res, 86(1-2), 76-83.

Redrobe J. P., Quirion R. (2001). Neuropeptide Y (NPY) as a potential target for the treatment of depressive illness: Y not?, Neurosci News, 4, 61-68.

Rockwood K., Black S., Gauthier S., Feldman H., Wentzell C. (2001). Clinical and neuroimaging findings in mixed dementia, Res Pract Alzheimer Dis, 5, 115-122.

Stage K. B., Bech P., Kragh-Sorensen P., Nair N., Katona C. (2001). Differences in symptomatology and diagnostic profile in younger and elderly depressed inpatients, J Affect Disord, 64(2-3), 239-48.

Tomossy G. F., Weisstub D. N., Gauthier S. (2001). Regulating ethical research involving cognitively impaired elderly subjects. Canada as a case study . In Weisstub D. N., Thomasma D. C., Gauthier S., Tomossy G. F. & Weisstub D. N. (Eds.) , Aging: Decisions at the End of Life (pp. 227-254). Kluwer Academic Publishers..

Valastro B., Ghribi O., Poirier J., Krzywkowski P., Massicotte G. (2001). AMPA receptor regulation and LTP in the hippocampus of young and aged apolipoprotein E-deficient mice, Neurobiol Aging, 22(1), 9-15.

Vaucher E., Aumont N., Pearson D., Rowe W., Poirier J., Kar S. (2001). Amyloid beta peptide levels and its effects on hippocampal acetylcholine release in aged, cognitively-impaired and -unimpaired rats, J Chem Neuroanat, 21(4), 323-9.

Wentzel C., Rockwood K., MacKnight C., Hachinski V., Hogan D. B., Feldman H., Ostbye T., Wolfson C., Gauthier S., Verreault R., McDowell I. (2001). Progression of impairment in patients with vascular cognitive impairment without dementia, Neurology, 57(4), 714-6.

Winblad B., Brodaty H., Gauthier S., Morris J. C., Orgogozo J. M., Rockwood K., Schneider L., Takeda M., Tariot P., Wilkinson D. (2001). Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?, Int J Geriatr Psychiatry, 16(7), 653-66.

Wood G. K., Marcotte E. R., Quirion R., Srivastava L. (2001). Strain differences in the behavioural outcome of neonatal ventral hippocampal lesions are determined by the postnatal environment and not genetic factors, Eur J Neurosci, 14(6), 1030-4.

de Leon M. J., Convit A., Wolf O. T., Tarshish C. Y., DeSanti S., Rusinek H., Tsui W., Kandil E., Scherer A. J., Roche A., Imossi A., Thorn E., Bobinski M., Caraos C., Lesbre P., Schlyer D., Poirier J., Reisberg B., Fowler J. (2001). Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET), Proc Natl Acad Sci U S A, 98(19), 10966-71.

Sort by :
By year :
  2024
  2023
  2022
  2021
  2020
  2019
  2018
  2017
  2016
  2015
  2014
  2013
  2012
  2011
  2010
  2009
  2008
  2007
  2006
  2005
  2004
  2003
  2002
  2001

[+] view more

path
send
share
share